Serratia marcescens: historical perspective and clinical review.
D000336:Aerosols; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001694:Biological Warfare; D002648:Child; D003428:Cross Infection / Q000453:epidemiology / Q000209:etiology; D004340:Drug Contamination; D004697:Endocarditis, Bacterial / Q000209:etiology; D004756:Enterobacteriaceae Infections / Q000188:drug therapy / Q000453:epidemiology / Q000635:transmission; D049690:History, Ancient; D049691:History, Medieval; D049711:History, Modern 1601-; D006801:Humans; D007275:Injections, Intravenous / Q000009:adverse effects; D008829:Microbiology / Q000266:history; D018805:Sepsis / Q000209:etiology; D012706:Serratia marcescens / Q000302:isolation & purification / Q000472:pathogenicity; D019966:Substance-Related Disorders / Q000150:complications; D014481:United States
D000336:Aerosols; D000900:Anti-Bacterial Agents